Serratus Plane Block and Pectointercostal Block

Postoperative Pain Clinical Trial

Official title:

Comparison of Deep Serratus Plane Block With Deep Serratus Plane Block+Pectointercostal Plane Block

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06381765
• Other study ID #: Serratus-Pectointercostal
• Status: Recruiting
• Phase: N/A
• Start date: May 10, 2024
• Est. completion date: August 10, 2024

Study information

• Verified date: May 2024
• Source: Cukurova University
• Contact: Ebru Biricik
• Phone: 05052420223
• Email: ebrubiricik01[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will recruit to the study. Patients will divide into 2 groups. Deep serratus plane block will perform with 0,25 %bupivacaine 20 ml at the midaxillary 5. rib, bilaterally for Group I. At Group II, deep serratus plane block ( 0,25 %bupivacaine 20 ml) at the midaxillary 5.th rib+ pectointercostal plane block (0,25% bupivacaine 15 ml) at 4-5.th intercostal space will perform bilaterally . General anesthesia with sevoflurane and remifentanil will perform to the all patients. Postoperative pain scores, morphine consumption and complications will record till the 24.th hours.

Description:

ASA I-II female patients aged over 18 who will undergoing breast reduction surgery will recruit to the study. General anesthesia with sevoflurane and remifentanil will perform to the all patients. Patients will divide into 2 groups. Serratus plane block for group I and serratus plane block+pectointercostal block for Group II will perform bilaterally. Ultrasound guided deep serratus plane block will perform with 0,25% bupivacaine 20 ml at the midaxillary 5. rib, for Group I. At Group II, ultrasound guided deep serratus plane block ( 0,25 %bupivacaine 20 ml) at the midaxillary 5.th rib+ pectointercostal plane block (0,25% bupivacaine 15 ml) at 4-5.th intercostal space will perform bilaterally. Patient controlled analgesia will perform with Morphine ( 1 mg bolus+ 10 min lockout+4 hours limit 10 mg) at postoperative period. Patients will evaluate with visual analogue scale (VAS) for postoperative pain scores till the first 24.th hours. Postoperative pain scores (VAS), morphine consumption and complications will record till the 24.th hours.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: August 10, 2024
• Est. primary completion date: August 10, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• ASA I-II patients

• Female

• who will undergoing Breast reduction surgery

Exclusion Criteria:

• ASA III and over patients

• who reject to join the study

• male gender

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Procedure:
• ultrasound guided Serratus plane bock and pectointercostal block
ultrasound guided serratus plane block (20 ml 0,25 %bupivacaine) will perform at the midaxillary 5.th rib and pectointercostal plane block (0,25% bupivacaine 15 ml) will perform at 4-5.th intercostal space. Both 2 blocks will perform bilaterally
• ultrasound guided Serratus plane bock
ultrasound guided serratus plane block (20 ml 0,25 %bupivacaine) will perform at the midaxillary 5.th rib to the all patients

Locations

Country	Name	City	State
Turkey	Çukurova University Faculty of Medicine	Adana

Sponsors (1)

Lead Sponsor	Collaborator
Cukurova University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative morphine consumption	Patient controlled analgesia with morphine will perform to the all patients and morphine consumption will calculate and record till the end of 24.th hours.	All the patients will follow till the postoperative 24.th hours and totally morphine consumption will record postoperative 24.th hours.
Primary	postoperative visual analog scale scores	All the patients will evaluate with visual analog scale scores (VAS) at the first postoperative 24.th hours period. VAS scores will define between 0-10 scores. 0 score means lowest pain score and 10 means the worst pain score.	VAS scores will record at the first postoperative 24.th hours